BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 21932171)

  • 1. Formononetin induces cell cycle arrest of human breast cancer cells via IGF1/PI3K/Akt pathways in vitro and in vivo.
    Chen J; Zeng J; Xin M; Huang W; Chen X
    Horm Metab Res; 2011 Sep; 43(10):681-6. PubMed ID: 21932171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptin-induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and down-regulation of tumor suppressor p53 and p21WAF1/CIP1.
    Chen C; Chang YC; Liu CL; Chang KJ; Guo IC
    Breast Cancer Res Treat; 2006 Jul; 98(2):121-32. PubMed ID: 16752079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor binding protein-3 induces G1 cell cycle arrest with inhibition of cyclin-dependent kinase 2 and 4 in MCF-7 human breast cancer cells.
    Kim HS; Lee WJ; Lee SW; Chae HW; Kim DH; Oh Y
    Horm Metab Res; 2010 Mar; 42(3):165-72. PubMed ID: 19960406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor 8 increases breast cancer cell growth by promoting cell cycle progression and by protecting against cell death.
    Nilsson EM; Brokken LJ; Härkönen PL
    Exp Cell Res; 2010 Mar; 316(5):800-12. PubMed ID: 19962979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formononetin-induced apoptosis by activation of Ras/p38 mitogen-activated protein kinase in estrogen receptor-positive human breast cancer cells.
    Chen J; Sun L
    Horm Metab Res; 2012 Dec; 44(13):943-8. PubMed ID: 22828872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formononetin promotes cell cycle arrest via downregulation of Akt/Cyclin D1/CDK4 in human prostate cancer cells.
    Li T; Zhao X; Mo Z; Huang W; Yan H; Ling Z; Ye Y
    Cell Physiol Biochem; 2014; 34(4):1351-8. PubMed ID: 25301361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417.
    Haluska P; Carboni JM; Loegering DA; Lee FY; Wittman M; Saulnier MG; Frennesson DB; Kalli KR; Conover CA; Attar RM; Kaufmann SH; Gottardis M; Erlichman C
    Cancer Res; 2006 Jan; 66(1):362-71. PubMed ID: 16397250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen and insulin/IGF-1 cooperatively stimulate cell cycle progression in MCF-7 breast cancer cells through differential regulation of c-Myc and cyclin D1.
    Mawson A; Lai A; Carroll JS; Sergio CM; Mitchell CJ; Sarcevic B
    Mol Cell Endocrinol; 2005 Jan; 229(1-2):161-73. PubMed ID: 15607540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formononetin inhibits migration and invasion of MDA-MB-231 and 4T1 breast cancer cells by suppressing MMP-2 and MMP-9 through PI3K/AKT signaling pathways.
    Zhou R; Xu L; Ye M; Liao M; Du H; Chen H
    Horm Metab Res; 2014 Oct; 46(11):753-60. PubMed ID: 24977660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formononetin-induced apoptosis of human prostate cancer cells through ERK1/2 mitogen-activated protein kinase inactivation.
    Ye Y; Hou R; Chen J; Mo L; Zhang J; Huang Y; Mo Z
    Horm Metab Res; 2012 Apr; 44(4):263-7. PubMed ID: 22328166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
    Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumol induces cell cycle arrest in colon cancer cells via reactive oxygen species and Akt/ GSK3β/cyclin D1 pathway.
    Wang J; Li XM; Bai Z; Chi BX; Wei Y; Chen X
    J Ethnopharmacol; 2018 Jan; 210():1-9. PubMed ID: 28684297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zanthoxyli Fructus induces growth arrest and apoptosis of LNCaP human prostate cancer cells in vitro and in vivo in association with blockade of the AKT and AR signal pathways.
    Yang Y; Ikezoe T; Takeuchi T; Adachi Y; Ohtsuki Y; Koeffler HP; Taguchi H
    Oncol Rep; 2006 Jun; 15(6):1581-90. PubMed ID: 16685399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclopentenone causes cell cycle arrest and represses cyclin D1 promoter activity in MCF-7 breast cancer cells.
    Hsiang CH; Straus DS
    Oncogene; 2002 Mar; 21(14):2212-26. PubMed ID: 11948404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the p38 MAPK/Akt/ERK1/2 signal pathways is required for the protein stabilization of CDC6 and cyclin D1 in low-dose arsenite-induced cell proliferation.
    Liu Y; Hock JM; Sullivan C; Fang G; Cox AJ; Davis KT; Davis BH; Li X
    J Cell Biochem; 2010 Dec; 111(6):1546-55. PubMed ID: 20862710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
    Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The natural antioxidant alpha-lipoic acid induces p27(Kip1)-dependent cell cycle arrest and apoptosis in MCF-7 human breast cancer cells.
    Dozio E; Ruscica M; Passafaro L; Dogliotti G; Steffani L; Marthyn P; Pagani A; Demartini G; Esposti D; Fraschini F; Magni P
    Eur J Pharmacol; 2010 Sep; 641(1):29-34. PubMed ID: 20580704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGF-1 activates hEAG K(+) channels through an Akt-dependent signaling pathway in breast cancer cells: role in cell proliferation.
    Borowiec AS; Hague F; Harir N; Guénin S; Guerineau F; Gouilleux F; Roudbaraki M; Lassoued K; Ouadid-Ahidouch H
    J Cell Physiol; 2007 Sep; 212(3):690-701. PubMed ID: 17520698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abrogation of p53 by its antisense in MCF-7 breast carcinoma cells increases cyclin D1 via activation of Akt and promotion of cell proliferation.
    Chhipa RR; Kumari R; Upadhyay AK; Bhat MK
    Exp Cell Res; 2007 Nov; 313(19):3945-58. PubMed ID: 17935714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.